SUPPRESSION OF THE NITRIC OXIDE PATHWAY IN METASTATIC RENAL CELL CARCINOMA PATIENTS RECEIVING VEGF-SIGNALING INHIBITORS

Therapies that target the vascular endothelial growth factor (VEGF) pathway cause hypertension but the mechanism remains unknown. This cross-sectional study tested the hypothesis that VEGF inhibition causes hypertension by suppressing VEGF-mediated vasodilatory pathways. Urine was collected from 80...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Robinson, Emily S., Khankin, Eliyahu V., Choueiri, Toni K., Dhawan, Mallika D., Rogers, Miranda J., Karumanchi, S. Ananth, Humphreys, Benjamin D.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3078049/
https://ncbi.nlm.nih.gov/pubmed/20956731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.110.160481
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items